Location: Home
  • search
  • go
  • Relate News
  • 11/26/2019Chi-Med's Surufatinib Granted Orphan Drug Designation by the USFDA
  • 11/25/2019NHSA Introduces BMI e-Voucher System as Beijing, Tianjin and Hebei Agr...
  • 11/25/2019Zhejiang Province Introduced Interim Rules for DRG Point-Based Payment
  • 11/25/2019New Report: Nearsightedness and Obesity Increased among the Chinese Ch...
  • 11/25/2019China Issues New Document to Step Up IP Protection Thru Increased Pena...
  • 11/22/2019Recent Executive Moves
  • 11/22/2019AmCham: Draft Implementation Regulations of PRC Foreign Investment Law...
  • 11/22/2019NMPA Issues Implementation Guide for ICH E2B(R3) - Individual Case Saf...
  • 11/22/2019Dr Reddy's Outsources Part of Manufacturing to Tap Local Market
  • 11/22/2019Chinese CMDO Pharmaron Raises $589M in HK Listing
  • 11/22/2019Chinese Biotechnology Dominates U.S. Senate Hearing
  • 11/21/2019Upcoming Event: Biologics Manufacturing Asia 2020
  • 11/21/2019CNIPA Issued Regulations On Collective Patent Examination
  • 11/21/2019Guidelines For Patent Examination Amended: Divisional, GUI, Subject Ma...
  • 11/21/2019NHC Issues Mobile Inspection Plan for Large Hospitals Between 2019 and...
  • 11/21/2019MIIT Announces 2nd Batch of Centralized Manufacturing Centers for Shor...
  • 11/21/201956 Listed Chinese Pharma Cos Had R&D Spending Above CNY 100M in 3Q...
  • 11/21/2019Senate Report Accuses China of Technology Theft
  • 11/21/2019NMPA Approves IND Application of MDI for Analgesic Penthrox
  • 11/21/2019Csafe Opens Shanghai Service Center For Pharma Containers
  • 11/21/2019Ascentage Breaks Ground on Its Global HQ, R&D Center and Manufactu...
  • 11/21/2019Real Can Pharma and Zheshang Bank in Supply Chain Finance Blockchain
  • 11/21/2019Fosun Pharma, MimiVax to Jointly Develop and Commercialize SurVaxM The...
  • 11/20/2019WuXi STA Forms Strategic Partnership with Impact Therapeutics
  • 11/20/2019Northeast Pharma under Anti-monopoly Investigation in Liaoning
  • 11/20/2019State Council Orders Prioritized Purchase of GQCE Essential Drugs with...
  • 11/20/2019Chinese Non-prescription Drug Sales Set to Reach CNY 250B by 2020
  • 11/20/2019LIDDS licensee Jiangxi Puheng Pharma Prepares for Phase III Trial in C...
  • 11/20/2019Mundipharma Accused of Using Fake Doctors, Misleading Claims to Drive ...
  • 11/19/2019Xian Janssen: Embrace Better Future with New Solutions
  • Page:273/789 Total number of articles:23668: [First][<<] [271] [272] [273] [274] [275] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group